To The Moon

$Hims & Hers Health Inc.(HIMS)$ $DEFIANCE DAILY TARGET 2X LONG HIMS ETF(HIMZ)$  🚀🧬📈 $HIMS: A Healthtech Platform Redefining Value in a Shifting Market 📈🧬🚀 I’ve just opened positions in Hims & Hers Health, Inc. ($HIMS), at an average of $54.02 per share, drawn by its compelling blend of operational strength, strategic evolution, and a technical setup that suggests a potential breakout. After digging into the company’s financials, market positioning, and broader economic context, I’m convinced that Hims is not just a telehealth provider but a vertically integrated healthtech platform that’s mispriced by conventional metrics. Below, I’ll walk through my analysis, weaving together technical

Hims & Hers Health, Inc. ( $Hims & Hers Health Inc.(HIMS)$ ) is stealing the spotlight, exploding nearly 16% in a single day after unveiling a jaw-dropping $1 billion funding round—the largest in its history. With the stock already boasting a 164% year-to-date (YTD) climb, it’s now perched at $64, tantalizingly close to its all-time peak of $72.98. Investors are buzzing: can HIMS keep the rocket fuel burning and blast past its record high in May? Let’s unpack the drivers, hurdles, and what’s next for this telehealth titan. 💰 Billion-Dollar Boost: What It Means The $1 billion cash infusion is a blockbuster move for HIMS. This isn’t just pocket change—it’s a war chest that could supercharge growth, from scaling its telehealth services to rol

Hims & Hers Health, Inc. (NASDAQ: HIMS) skyrocketed nearly 16% on Tuesday, catching the attention of investors. This rally was sparked by news that the telehealth company successfully raised $1 billion in its largest funding round to date—a bold move that signals major growth ambitions and investor confidence. So far in 2025, the stock has been nothing short of a rocket ship, surging over 150% year-to-date. Currently trading around $60.50, HIMS is sitting well above its 52-week low of $13.47, though still below its 52-week high of $72.98. With momentum building and strong financials backing the story, the question is clear: Could HIMS be on its way to setting a new all-time high this May? Hims & Hers Health Inc. (HIMS) What’s Fueling the Momentum? Massive Capital Injection: The rec

Hims & Hers Health, Inc. ( $Hims & Hers Health Inc.(HIMS)$ ) is riding a wave of momentum, surging nearly 16% on Tuesday to close at $64, just shy of its all-time high of $72.98. The telehealth company’s $1 billion funding round—the largest in its history—has fueled this rally, pushing its year-to-date (YTD) gain to an eye-popping 164%. With the stock tantalizingly close to new heights, investors are buzzing: Can HIMS break out in May, or is this the peak? Let’s dive into the catalysts, risks, and trading strategies to see if this healthcare disruptor is your next big win. Hims & Hers Health: A Telehealth Titan Hims & Hers Health is revolutionizing healthcare with its direct-to-consumer telehealth platform, offering personalized tr

Is Hims still to buy?

$Hims & Hers Health Inc.(HIMS)$ $HIMS is bullish don't be fooled the news is positive

$Hims & Hers Health Inc.(HIMS)$

$Hims & Hers Health Inc.(HIMS)$ snap back rally tomorrow?

$Hims & Hers Health Inc.(HIMS)$ Like if you think $HIMS can reach $100 this year

$Hims & Hers Health Inc.(HIMS)$ After a 100% run, HIMS might be priced for perfection. Here's why I’d be cautious here:💸 Valuation Risk: At these levels, even small execution misses could trigger big sell-offs.🏥 Competition Rising: Telehealth space is crowded—big players like Amazon and CVS are circling.🔍 Still Unproven in Some Verticals: Their push into GLP-1 weight-loss drugs and mental health is early-stage and high-risk.Momentum traders may stay in, but long-term investors should wait for a better entry. Chasing at the top rarely ends well.

$Hims & Hers Health Inc.(HIMS)$ HIMS is up 100% YTD, but this could just be the beginning. Here’s why I believe there’s still upside:📈 Profitability Just Kicked In: The company turned EBITDA positive, signaling a sustainable growth model.🌐 Massive TAM in Telehealth: HIMS is expanding beyond men’s wellness into mental health, weight loss, and primary care—a $300B+ market.📊 Strong Brand Loyalty: Its direct-to-consumer model with sleek branding creates stickiness many rivals lack.Yes, it’s doubled—but compared to peers, it’s still reasonably valued. If execution holds, HIMS could still have plenty of room to run.

$Hims & Hers Health Inc.(HIMS)$  madness to go up so much. This is a hot stock. However recently it has went up so much, it's due pullback. Stock financials is strong with outstanding growth and no debt. Worth a consideration when it drops to support on the moving averages. Watchlist!   

1. $Hims & Hers Health Inc.(HIMS)$ What is the superpower of Hims & Hers?It's the aggregator of demand in healthcare. CVS doesn't "own" demand. Your doctor doesn't have power over pharma companies.Hims & Hers can pull together the demand of millions of people to make the experience better!2. $Walt Disney(DIS)$ Disney is spending $60 billion over a decade to expand parks and experiences.But this brand new theme park in Abu Dhabi will require ZERO capital. It's entirely upside for Disney.ImageFor whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!Find out

$HIMS 20250509 50.0 CALL$  

I opened $Hims & Hers Health Inc.(HIMS)$  ,I opened $Hims & Hers Health Inc.(HIMS)$ ,Take a look at the latest order I posted！ Bought more hims

Hey TigersDuring the recent 5 trading days, there are numerous stocks achieved impressive double-digit gains.Below is a list of the top ten featuring companies with a market cap over $1 billion, daily trading volume exceeding $1 million, and gains over 20%.Have you held any stocks that have brought you good returns? Are you familiar with these winners?Based on the ranking table, here's a summary of the reasons for the rise and future expectations of the ten listed companies, hoping it will help you better understand them.A gentle reminder: Past performance is not indicative of future price increases. Analyze and plan for risks from multiple perspectives before any trade.1. $Pony AI Inc(PONY)$ Leads with a 48% GainKey News and

$Hims & Hers Health Inc.(HIMS)$ is up 88% since we called it out in April — and just today it ran 30% intraday.Our entry? Right off the Smart Money Zone at $28–$30.Our target? Still eyeing a gap fill to $57–$60 in the coming weeks.Yes, I’ve started scaling out.No, I’m not upset about it.📉 Expansion like this doesn’t last forever — and we don’t time tops. We trade systems. 👇For whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!Find out more here：Trade on a Cash Boost Account and enjoy up to 6 months of Commission-Free trading.💰Join the TB Contra Telegr

$Berkshire Hathaway(BRK.A)$ $Palantir Technologies Inc.(PLTR)$ $Hims & Hers Health Inc.(HIMS)$ 📰📊📅 The Week So Far: Legends Exit, Leaders Emerge 📅📊📰 Warren Buffett, the Oracle of Omaha, is stepping down as CEO of Berkshire Hathaway after more than 60 iconic years. At 94, he hands over the reins of a $1T+ empire built on patience, discipline, and 5,500,000% worth of compounded genius. $1 into $55,000. No hype, just history! 🚨📰🗞️ But Buffett isn’t the only headline… This week so far: 🪙 $BRK Buffett bows out 🕵️ $PLTR Palantir accelerates ↗️ $AMD stuns with guidance 🏎️ $RACE flexes pricing power 💊 $HIMS rebrands and rallies ⚡️ $CELH heats up with Alani Markets a

Market OverviewU.S. stocks were lower for a second straight session on Tuesday(May 6) as comments from U.S. President Donald Trump and Treasury Secretary Scott Bessent provided little clarity to the timeline for any trade deals.Regarding the options market, a total volume of 40,278,298 contracts was traded.Top 10 Option VolumesTop 10: $Palantir(PLTR)$, $Nvidia(NVDA)$, $Tesla(TSLA)$, $Hims & Hers Health(HIMS)$, $AMD(AMD)$, $Apple(AAPL)$, $Amazon.com(AMZN)$,

HIMS stock surged 41% over the past week and is now up 104% year-to-date!As a high-growth player in the AI + healthcare space, HIMS has seen dramatic ups and downs. Once heavily shorted and surrounded by skepticism, what changed to help it win back the market’s confidence?Some visionary investors positioned themselves early and earned big — especially those who used options to magnify their returns. Here are a few highlights from the community:🎉 Huge congrats to @lllsong for locking in 3713% return by buying $Hims & Hers Health Inc.(HIMS)$ call.🎉 Huge congrats to @Shernice軒嬣 2000 for securing 101% return by buying

$Hims & Hers Health Inc.(HIMS)$ $DEFIANCE DAILY TARGET 2X LONG HIMS ETF(HIMZ)$  🚀🧬📈 $HIMS: A Healthtech Platform Redefining Value in a Shifting Market 📈🧬🚀 I’ve just opened positions in Hims & Hers Health, Inc. ($HIMS), at an average of $54.02 per share, drawn by its compelling blend of operational strength, strategic evolution, and a technical setup that suggests a potential breakout. After digging into the company’s financials, market positioning, and broader economic context, I’m convinced that Hims is not just a telehealth provider but a vertically integrated healthtech platform that’s mispriced by conventional metrics. Below, I’ll walk through my analysis, weaving together technical

Hims & Hers Health, Inc. ( $Hims & Hers Health Inc.(HIMS)$ ) is stealing the spotlight, exploding nearly 16% in a single day after unveiling a jaw-dropping $1 billion funding round—the largest in its history. With the stock already boasting a 164% year-to-date (YTD) climb, it’s now perched at $64, tantalizingly close to its all-time peak of $72.98. Investors are buzzing: can HIMS keep the rocket fuel burning and blast past its record high in May? Let’s unpack the drivers, hurdles, and what’s next for this telehealth titan. 💰 Billion-Dollar Boost: What It Means The $1 billion cash infusion is a blockbuster move for HIMS. This isn’t just pocket change—it’s a war chest that could supercharge growth, from scaling its telehealth services to rol

Hims & Hers Health, Inc. ( $Hims & Hers Health Inc.(HIMS)$ ) is riding a wave of momentum, surging nearly 16% on Tuesday to close at $64, just shy of its all-time high of $72.98. The telehealth company’s $1 billion funding round—the largest in its history—has fueled this rally, pushing its year-to-date (YTD) gain to an eye-popping 164%. With the stock tantalizingly close to new heights, investors are buzzing: Can HIMS break out in May, or is this the peak? Let’s dive into the catalysts, risks, and trading strategies to see if this healthcare disruptor is your next big win. Hims & Hers Health: A Telehealth Titan Hims & Hers Health is revolutionizing healthcare with its direct-to-consumer telehealth platform, offering personalized tr

Hey TigersDuring the recent 5 trading days, there are numerous stocks achieved impressive double-digit gains.Below is a list of the top ten featuring companies with a market cap over $1 billion, daily trading volume exceeding $1 million, and gains over 20%.Have you held any stocks that have brought you good returns? Are you familiar with these winners?Based on the ranking table, here's a summary of the reasons for the rise and future expectations of the ten listed companies, hoping it will help you better understand them.A gentle reminder: Past performance is not indicative of future price increases. Analyze and plan for risks from multiple perspectives before any trade.1. $Pony AI Inc(PONY)$ Leads with a 48% GainKey News and

Hims & Hers Health, Inc. (NASDAQ: HIMS) skyrocketed nearly 16% on Tuesday, catching the attention of investors. This rally was sparked by news that the telehealth company successfully raised $1 billion in its largest funding round to date—a bold move that signals major growth ambitions and investor confidence. So far in 2025, the stock has been nothing short of a rocket ship, surging over 150% year-to-date. Currently trading around $60.50, HIMS is sitting well above its 52-week low of $13.47, though still below its 52-week high of $72.98. With momentum building and strong financials backing the story, the question is clear: Could HIMS be on its way to setting a new all-time high this May? Hims & Hers Health Inc. (HIMS) What’s Fueling the Momentum? Massive Capital Injection: The rec

Market OverviewU.S. stocks were lower for a second straight session on Tuesday(May 6) as comments from U.S. President Donald Trump and Treasury Secretary Scott Bessent provided little clarity to the timeline for any trade deals.Regarding the options market, a total volume of 40,278,298 contracts was traded.Top 10 Option VolumesTop 10: $Palantir(PLTR)$, $Nvidia(NVDA)$, $Tesla(TSLA)$, $Hims & Hers Health(HIMS)$, $AMD(AMD)$, $Apple(AAPL)$, $Amazon.com(AMZN)$,

HIMS stock surged 41% over the past week and is now up 104% year-to-date!As a high-growth player in the AI + healthcare space, HIMS has seen dramatic ups and downs. Once heavily shorted and surrounded by skepticism, what changed to help it win back the market’s confidence?Some visionary investors positioned themselves early and earned big — especially those who used options to magnify their returns. Here are a few highlights from the community:🎉 Huge congrats to @lllsong for locking in 3713% return by buying $Hims & Hers Health Inc.(HIMS)$ call.🎉 Huge congrats to @Shernice軒嬣 2000 for securing 101% return by buying

1. $Hims & Hers Health Inc.(HIMS)$ What is the superpower of Hims & Hers?It's the aggregator of demand in healthcare. CVS doesn't "own" demand. Your doctor doesn't have power over pharma companies.Hims & Hers can pull together the demand of millions of people to make the experience better!2. $Walt Disney(DIS)$ Disney is spending $60 billion over a decade to expand parks and experiences.But this brand new theme park in Abu Dhabi will require ZERO capital. It's entirely upside for Disney.ImageFor whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!Find out

$Berkshire Hathaway(BRK.A)$ $Palantir Technologies Inc.(PLTR)$ $Hims & Hers Health Inc.(HIMS)$ 📰📊📅 The Week So Far: Legends Exit, Leaders Emerge 📅📊📰 Warren Buffett, the Oracle of Omaha, is stepping down as CEO of Berkshire Hathaway after more than 60 iconic years. At 94, he hands over the reins of a $1T+ empire built on patience, discipline, and 5,500,000% worth of compounded genius. $1 into $55,000. No hype, just history! 🚨📰🗞️ But Buffett isn’t the only headline… This week so far: 🪙 $BRK Buffett bows out 🕵️ $PLTR Palantir accelerates ↗️ $AMD stuns with guidance 🏎️ $RACE flexes pricing power 💊 $HIMS rebrands and rallies ⚡️ $CELH heats up with Alani Markets a

Hello everyone! Today i want to share some technical analysis with you!1. $Hims & Hers Health Inc.(HIMS)$ A perfect test of the 2/19 pivot VWAP before blastoff today.Image2. $CleanSpark, Inc.(CLSK)$ Inverse head & shoulders attempting to set up on the daily candle chart.Image3. $SPDR S&P 500 ETF Trust(SPY)$ According to Polymarket, there's a 2.1% chance that the Fed decreases rates by 25 bps tomorrow....So you're telling me there's a chance....Image4. $JD.com(JD)$ Bull flag on the daily chart.ImageOpen a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stock

$Hims & Hers Health Inc.(HIMS)$ is up 88% since we called it out in April — and just today it ran 30% intraday.Our entry? Right off the Smart Money Zone at $28–$30.Our target? Still eyeing a gap fill to $57–$60 in the coming weeks.Yes, I’ve started scaling out.No, I’m not upset about it.📉 Expansion like this doesn’t last forever — and we don’t time tops. We trade systems. 👇For whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!Find out more here：Trade on a Cash Boost Account and enjoy up to 6 months of Commission-Free trading.💰Join the TB Contra Telegr

$Hims & Hers Health Inc.(HIMS)$ HIMS is up 100% YTD, but this could just be the beginning. Here’s why I believe there’s still upside:📈 Profitability Just Kicked In: The company turned EBITDA positive, signaling a sustainable growth model.🌐 Massive TAM in Telehealth: HIMS is expanding beyond men’s wellness into mental health, weight loss, and primary care—a $300B+ market.📊 Strong Brand Loyalty: Its direct-to-consumer model with sleek branding creates stickiness many rivals lack.Yes, it’s doubled—but compared to peers, it’s still reasonably valued. If execution holds, HIMS could still have plenty of room to run.

$Hims & Hers Health Inc.(HIMS)$ Wednesday there may be a pullback to $47 because day traders could not get in at the close and see a little more at open. Then at 10 to 11 this should go to $53 then by 2 pm be near $55. If there are not many shorts we end the session near $60 and may go to $63. It truly all depends on the Fed news Wednesday but this stock should not suffer either way as people are proud and many vain. We will see this stock go to new highs by Friday and if any mergers or other good news comes out $90 by next Wednesday and $100 in 10 days

$Hims & Hers Health Inc.(HIMS)$ After a 100% run, HIMS might be priced for perfection. Here's why I’d be cautious here:💸 Valuation Risk: At these levels, even small execution misses could trigger big sell-offs.🏥 Competition Rising: Telehealth space is crowded—big players like Amazon and CVS are circling.🔍 Still Unproven in Some Verticals: Their push into GLP-1 weight-loss drugs and mental health is early-stage and high-risk.Momentum traders may stay in, but long-term investors should wait for a better entry. Chasing at the top rarely ends well.

$Hims & Hers Health Inc.(HIMS)$ $HIMS is bullish don't be fooled the news is positive

$Hims & Hers Health Inc.(HIMS)$

$Hims & Hers Health Inc.(HIMS)$  madness to go up so much. This is a hot stock. However recently it has went up so much, it's due pullback. Stock financials is strong with outstanding growth and no debt. Worth a consideration when it drops to support on the moving averages. Watchlist!   

$Hims & Hers Health Inc.(HIMS)$ Like if you think $HIMS can reach $100 this year

Is Hims still to buy?

$Hims & Hers Health Inc.(HIMS)$ snap back rally tomorrow?